IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence, ...

The Global Generative AI In Chemical Market is expected to grow at a compound annual growth rate (CAGR) of 29.8% between 2025 ...

Terumo Blood and Cell Technologies (Terumo BCT), and FUJIFILM Irvine Scientific have announced a strategic collaboration to help accelerate T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion ...

Pharmapack Europe & CPHI have outlined key trends for pharma in 2025, highlighting the return of funding liquidity—via increased VC investments and PE capital for M&A—alongside enhanced supply chain ...

Domino Printing Sciences (Domino) is pleased to announce the launch of its new Mx-Series electric pallet labeller – the Mx350i-eP. The new, electrically driven pallet labeller boasts a suite of smart ...

As the NHS faces another winter of unprecedented pressures, leading scientific organisations The Physiological Society and PHG Foundation, release a new report that proposes an innovative, data-driven ...

Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the supplemental New Drug Application for ORPATHYS® (savolitinib) has been granted approval by the China National Medical Products ...

Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) is pleased to report on progress being made by Neurocrine Biosciences, Inc. (“Neurocrine”) regarding the clinical development of its ...

One-year follow-up data confirm favorable safety profile of BellaSeno´s scaffolds compared to silicone implantsCompany plans expansion to primary breast augmentation and lumpectomyLeipzig, Germany/ ...

NORTH CHICAGO, Ill. and SHANGHAI, Jan. 13, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) today announced an option to ...

Integrated DNA Technologies Names Ajay Gannerkote as New President to Lead Bold Era of Innovation and GrowthExperienced healthcare leader with more than 20 years of demonstrated success driving ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumour DNA can predict lung cancer outcome in a Cancer Research UK-funded study.